share_log

Evogene Q4 EPS $(0.13) Beats $(0.14) Estimate, Sales $578.00K Beat $500.00K Estimate

Moomoo 24/7 ·  Mar 7 07:05

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 85.71 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $578.00 thousand.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment